* Treace Medical Concepts Inc TMCI.OQ reported a quarterly
adjusted loss of 31 cents per share for the quarter ended in
June. The mean expectation of four analysts for the quarter was
for a loss of 20 cents per share.
* Revenue rose 45.1% to $29.97 million from a year ago;
analysts
expected $28.63 million.
* Treace Medical Concepts Inc's reported EPS for the quarter
was a
loss of 31 cents.
* The mean earnings estimate of analysts had risen by
about 3.5%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Treace Medical Concepts Inc shares had risen by 37.4% this
quarter and gained 5.7% so far this year.
* The company reported a quarterly loss of $17.23 million.
* Wall Street's median 12-month price target for Treace
Medical
Concepts Inc is $22.00
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 10
at 12:31 a.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.20 -0.31 Missed
Mar. 31 2022 -0.20 -0.16 Beat
Dec. 31 2021 0.00 -0.12 Missed
Sep. 30 2021 -0.12 -0.12 Met